Immediate Impact
1 by Nobel laureates 68 standout
Citing Papers
Catalytic Asymmetric Construction of Chiral Polysubstituted 3-Azabicyclo[3.1.1]heptanes by Copper-Catalyzed Stereoselective Formal [4π+2σ] Cycloaddition
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Oliver Boix being referenced
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
2022
Phase 1 study of pasotuxizumab (BAY 2010112), a PSMA-targeting Bispecific T cell Engager (BiTE) immunotherapy for metastatic castration-resistant prostate cancer (mCRPC).
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Oliver Boix | 488 | 224 | 221 | 19 | 727 | |
| Bernardo Queralt | 483 | 266 | 170 | 23 | 663 | |
| Jian-Ming Xu | 569 | 335 | 165 | 15 | 803 | |
| Simone Steinbild | 469 | 251 | 342 | 18 | 827 | |
| Marianna Silletta | 215 | 204 | 153 | 39 | 594 | |
| Krzysztof Jeziorski | 463 | 255 | 102 | 24 | 791 | |
| Kian Fong Foo | 311 | 232 | 138 | 24 | 694 | |
| Jacqueline Duffour | 539 | 202 | 143 | 23 | 788 | |
| Naomi Laing | 445 | 179 | 359 | 31 | 784 | |
| Colin Germond | 495 | 159 | 212 | 20 | 780 | |
| Muaiad Kittaneh | 440 | 306 | 290 | 40 | 722 |
All Works
Login with ORCID to disown or claim papers
Loading papers...